(Q45928209)

17 December 2017

title

Macrolide-induced digoxin toxicity: a population-based study. (English)

1 reference

17 December 2017

0 references

T Gomes

1

1 reference

17 December 2017

M M Mamdani

series ordinal

2

1 reference

17 December 2017

D N Juurlink

series ordinal

3

1 reference

17 December 2017

language of work or name

English

0 references

publication date

15 July 2009

1 reference

17 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

17 December 2017

volume

86

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

383-386

1 reference

17 December 2017

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

A prospective study of the clarithromycin-digoxin interaction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Macrolide drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Pharmacokinetic drug interactions of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Comparative safety of the different macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

Drug-Induced Lithium Toxicity in the Elderly: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.127

21 January 2018

Identifiers

DOI

10.1038/CLPT.2009.127

1 reference

17 December 2017

1 reference

17 December 2017